Cocrystal PharmaCOCP
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 24 institutions reported holding Cocrystal Pharma Inc. (COCP) in their 13F filings, unchanged from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($391K), Renaissance Technologies ($178K) and BlackRock, Inc. ($105K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cocrystal Pharma Inc.
- CUSIP
- 19188J409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $98K |
| Exits | 2 | $20K |
All 13F filers, Q4 2024 → Q1 2025: 106,894 shares bought and 69,510 shares sold, net +37,384 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | No change | 275,656 | $391K |
| Renaissance Technologies | 0.00% | Reduce -0.2% | 125,628 | $178K |
| BlackRock, Inc. | 0.00% | No change | 73,746 | $105K |
| Geode Capital Management, LLC | 0.00% | Add +6.1% | 73,119 | $104K |
| Neuberger Berman Group LLC | 0.00% | New | 59,271 | $84K |
| Susquehanna International Group, LLP | 0.00% | Add +177.8% | 33,683 | $48K |
| State Street Corp. | 0.00% | No change | 20,543 | $29K |
| UBS Group AG | 0.00% | Add +174.2% | 16,806 | $24K |
| Parallel Advisors, LLC | 0.00% | No change | 15,228 | $22K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.8% | 14,596 | $21K |
| Northern Trust Corp. | 0.00% | Reduce -2.0% | 11,921 | $17K |
| Citadel Advisors | 0.00% | New | 10,034 | $14K |
| Bank of America Corp. | 0.00% | Add +0.0% | 9,022 | $13K |
| Morgan Stanley | 0.00% | Reduce -90.9% | 5,863 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +135.8% | 1,957 | $3K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 817 | $1K |
| Clean Yield Group | 0.00% | No change | 418 | $594 |
| MAI Capital Management | 0.00% | No change | 237 | $337 |
| JPMorgan Chase & Co. | 0.00% | Reduce -59.9% | 104 | $148 |
| Nvwm, LLC | 0.00% | No change | 84 | $119 |
| SBI Securities Co., Ltd. | 0.00% | No change | 33 | $47 |
| Wells Fargo & Company | 0.00% | No change | 6 | $9 |
| Activest Wealth Management | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 51 | $0 |
"% of holder's portfolio" is COCP's weight in each manager's 13F, not the share of Cocrystal Pharma Inc. the manager owns.